Researchers reported an overall 73% 30-day survival rate in the small study of patients with right ventricular heart failure, according to data Abiomed released during the Transcatheter Cardiovascular Therapeutics conference in Washington D.C.
Cook Medical named Rob Lyles executive vice president, the latest move in a larger management shift at the Indiana medtech maker.
Lyles was formerly vice president of Cook’s peripheral intervention division. He has been with the company since 2003 and was named division VP in 2007. Lyles’ promotion follows the advancement of Pete Yonkman to president of the Cook Medical. Mark Breedlove, a 19-year veteran of Cook Medical, will succeed Lyles as VP of the peripheral intervention division.
Accellent names new COO, president
Massachusetts medtech manufacturer Accellent Inc. shuffled its C-Suite, promoting Jeremy Friedman from CFO to president and COO of the cardio & vascular business, in addition to his duties as executive vice president.
MASSDEVICE ON CALL — Health records from hospitals in 26 states that was later sold to researchers and companies contained data that could be linked to individuals, raising concerns about how differing levels of compliance with data redaction standards put patients’ privacy at risk, Bloomberg reported.
InspireMD (OTC:NSPR) presented new 6-month follow up data for its MASTER trial showing lower mortality rates in patients treated with its MGuard stent. The company’s findings were presented today at the STEMI symposium of the annual EuroPCR meeting in Paris, France.
The trial measured all-cause mortality for patients treated with the company’s MGuard stents compared to a control group treated with bare metal stents or drug-eluting stents.